These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 3125990)

  • 1. [Effect of hydralazine on the pulmonary arterial hypertension in monocrotaline induced cor pulmonale in Macacus rhesus].
    Sun BT
    Zhonghua Jie He He Hu Xi Za Zhi; 1987 Aug; 10(4):229-30, 255, 15. PubMed ID: 3125990
    [No Abstract]   [Full Text] [Related]  

  • 2. [Monocrotaline-induced cor pulmonale in the rhesus monkey: ultrastructural changes of lung and heart].
    Sun BT
    Zhonghua Jie He He Hu Xi Za Zhi; 1987 Apr; 10(3):148-51, 191, 11-2. PubMed ID: 3130198
    [No Abstract]   [Full Text] [Related]  

  • 3. [Pulmonary circulatory disturbance due to pulmonary peripheral lesions--etiology of experimental pulmonary hypertension and cor pulmonale].
    Watanabe S
    Kokyu To Junkan; 1981 May; 29(5):481-5. PubMed ID: 6797009
    [No Abstract]   [Full Text] [Related]  

  • 4. Fibrin thrombosis in monocrotaline pyrrole-induced cor pulmonale in rats.
    Lalich JL; Johnson WD; Raczniak TJ; Shumaker RC
    Arch Pathol Lab Med; 1977 Feb; 101(2):69-73. PubMed ID: 138406
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of methylprednisolone on monocrotaline-induced pulmonary vascular disease and right ventricular hypertrophy.
    Langleben D; Reid LM
    Lab Invest; 1985 Mar; 52(3):298-303. PubMed ID: 3156262
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endocardial fibrosis associated with monocrotaline-induced pulmonary hypertension in nonhuman primates (Macaca arctoides).
    Chesney CF; Allen JR
    Am J Vet Res; 1973 Dec; 34(12):1577-81. PubMed ID: 4271643
    [No Abstract]   [Full Text] [Related]  

  • 7. Treatment of pulmonary hypertension with diltiazem in a child with bronchopulmonary dysplasia.
    Kasian GF; Ninan A; Duncan WJ; Bingham WT; Mersal A; Tyrrell MJ; Sankaran K
    Can J Cardiol; 1988 May; 4(4):181-4. PubMed ID: 3395914
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CPU0213, a non-selective ETA/ETB receptor antagonist, improves pulmonary arteriolar remodeling of monocrotaline-induced pulmonary hypertension in rats.
    Cui B; Cheng YS; Dai DZ; Li N; Zhang TT; Dai Y
    Clin Exp Pharmacol Physiol; 2009 Feb; 36(2):169-75. PubMed ID: 18986320
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiremodeling effects of iloprost and the dual-selective phosphodiesterase 3/4 inhibitor tolafentrine in chronic experimental pulmonary hypertension.
    Schermuly RT; Kreisselmeier KP; Ghofrani HA; Samidurai A; Pullamsetti S; Weissmann N; Schudt C; Ermert L; Seeger W; Grimminger F
    Circ Res; 2004 Apr; 94(8):1101-8. PubMed ID: 15031263
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polyamine content in pulmonary arteries from rats with monocrotaline-induced pulmonary hypertension.
    Orlinska U; Olson JW; Gillespie MN
    Res Commun Chem Pathol Pharmacol; 1988 Nov; 62(2):187-94. PubMed ID: 3150791
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The mechanism of the development of pulmonary hypertension induced by monocrotaline in rats].
    Kataoka R; Tobise K
    Nihon Kyobu Shikkan Gakkai Zasshi; 1987 May; 25(5):563-73. PubMed ID: 3118089
    [No Abstract]   [Full Text] [Related]  

  • 12. [Reduction of the development of monocrotaline-induced pulmonary hypertension in rats by artificial unilateral pneumothorax].
    Sugita T; Sawada A; Kuriyama T; Yamagishi F; Kohchi F; Naitoh T; Kakusaka I; Okada O; Watanabe S; Ogata T
    Nihon Kyobu Shikkan Gakkai Zasshi; 1985 Nov; 23(11):1328-36. PubMed ID: 3937926
    [No Abstract]   [Full Text] [Related]  

  • 13. [Mast cell hyperplasia in monocrotaline-induced pulmonary changes in rats].
    Kuriyama T; Sawada A; Sugita T; Watanabe S; Shen SY; Hiroshima K; Hayashi Y
    Nihon Kyobu Shikkan Gakkai Zasshi; 1985 Aug; 23(8):865-72. PubMed ID: 3935842
    [No Abstract]   [Full Text] [Related]  

  • 14. Hemodynamic effect of hydralazine in interstitial lung disease patients with cor pulmonale. Immediate and short-term evaluation at rest and during exercise.
    Lupi-Herrera E; Seoane M; Verdejo J; Gomez A; Sandoval J; Barrios R; Martinez W
    Chest; 1985 May; 87(5):564-73. PubMed ID: 3987368
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pathophysiological study on monocrotaline-induced pulmonary hypertension in rats (author's transl].
    Kido M
    Fukuoka Igaku Zasshi; 1981 Mar; 72(3):117-30. PubMed ID: 6790398
    [No Abstract]   [Full Text] [Related]  

  • 16. [Monocrotaline-induced pulmonary hypertension with special reference to the influence of dose, age, and sex].
    Sawada A; Kuriyama T; Sugita T; Watanabe S
    Nihon Kyobu Shikkan Gakkai Zasshi; 1985 May; 23(5):578-83. PubMed ID: 3932735
    [No Abstract]   [Full Text] [Related]  

  • 17. Ultrastructure of the right ventricle after monocrotaline-induced cor pulmonale in the nonhuman primate (Macaca arctoides).
    Raczniak TJ; Chesney CF; Allen JR
    Exp Mol Pathol; 1978 Feb; 28(1):107-18. PubMed ID: 413738
    [No Abstract]   [Full Text] [Related]  

  • 18. Experimental study on monocrotaline induced pulmonary hypertensive rats. (1) Effect of long-term injection of immunosuppressant.
    Tanabe T; Furuya H; Kanemoto N; Goto Y; Hata J
    Tokai J Exp Clin Med; 1981 Jan; 6(1):41-8. PubMed ID: 6789505
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Morphological study of monocrotaline-induced pulmonary hypertension in rats].
    Nakashima M
    Nihon Kyobu Shikkan Gakkai Zasshi; 1983 Mar; 21(3):227-39. PubMed ID: 6415328
    [No Abstract]   [Full Text] [Related]  

  • 20. [Therapeutic principles in pulmonary hypertension and cor pulmonale].
    Kohl FV
    Internist (Berl); 1988 Oct; 29(10):688-96. PubMed ID: 3069780
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.